Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Max-Planck-Gesellschaft zur Frderung der Wissenschaften e.V. et al v. Whitehead Institute for Biomedical Research et al
Case Number:
1:09-cv-11116
Court:
Nature of Suit:
Judge:
Firms
Sectors & Industries:
-
March 15, 2011
Alnylam, German Group Settle RNA Patent App Case
Alnylam Pharmaceuticals Inc. and a German research organization on Tuesday settled their contract suit against a Massachusetts-based biomedical research group and a college trustee board over the prosecution of two families of RNA interference patent applications.
-
February 08, 2011
UMass Gets Unfair Enrichment Claim Nixed In IP Suit
A federal judge has approved the University of Massachusetts' bid to trim a claim from a suit over RNA interference patents from Max Planck Institute and Alnylam Pharmaceuticals Inc.
-
June 14, 2010
Claims Pared In Max Planck RNA Patent License Suit
The Whitehead Institute for Biomedical Research and the University of Massachusetts have won a partial dismissal of the Max Planck Institute's lawsuit over the licensing of RNA interference patents, though a federal judge left breach of contract and other claims against the defendants intact.
-
February 26, 2010
MIT Seeks To Exit Max Planck RNA Patent Suit
The Massachusetts Institute of Technology and the Max Planck Institute have filed a joint motion to dismiss the university from Max Planck's suit over RNA interference patents, following MIT's agreement to be bound by any declaratory judgment against its co-defendants.
-
February 11, 2010
Jury To Hear Max Planck RNA Interference Patent Suit
A magistrate judge has denied a bid by the Whitehead Institute for Biomedical Research, the Massachusetts Institute of Technology and the University of Massachusetts to strike the Max Planck Institute's demand for a jury in a suit over the licensing of RNA interference patents worth millions.